We'll have to wait another month to find out. However, the late April AACR 2020 meeting sounds like a promising venue for Zenith's ZEN-3694 prostate cancer results to be presented.

https://www.aacr.org/meeting/aacr-annual-meeting-2020/spotlight-on-clinical-trials/

Final results and conclusions for placeholder abstracts are due by February 20, 2020 (today!).

EMBARGO POLICY AND ONLINE PUBLICATION OF ABSTRACTS

In accordance with the AACR’s embargo policy, the content of abstracts must be kept confidential until they are made publicly available.

The titles and authors of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner no earlier than 4:30 p.m. U.S. ET on Tuesday, March 24, 2020.

The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 3 p.m. U.S. PT (6 p.m. U.S. ET) on Friday, April 24, 2020, except those abstracts that are selected for inclusion in the AACR press program. Abstracts that are featured in the AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.

If not AACR, then there is the May 29 to June 2nd ASCO meeting 

https://meetings.asco.org/am/dates-know

Abstract Submission Deadline: FEBRUARY 11, 2020 AT 11:59 PM ET

Late-Breaking Data Submission Deadline: MARCH 12, 2020 AT 11:59 PM ET (Authors must submit a shell/placeholder by the February 11, 2020, deadline to be considered for Late-Breaking Submission)